RTRAF and brain cancer: Guo et al. [11] and Cur et al. [12] showed that expression of C14ORF166 was significantly associated with an aggressive phenotype in pancreatic carcinoma, and Wang et al. [10] reported that expression of C14ORF166 was associated with poor prognostic factors in brain cancer.